Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus

<b>Objectives</b>: Tacrolimus, a Biopharmaceutics Classification System (BCS) class II drug, is widely used for transplant patients to prevent graft rejection. To enhance its bioavailability, amorphous solid dispersion (ASD) formulations were developed and evaluated. The release properties of severa...

Descrición completa

Detalles Bibliográficos

Principais autores:	Evangelos Karakitsios, Maria-Faidra-Galini Angelerou, Iasonas Kapralos, Georgia Tsakiridou, Lida Kalantzi, Aristides Dokoumetzidis
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-02-01
Series:	Pharmaceutics
Assuntos:	physiologically based biopharmaceutics model amorphous solid dispersion biorelevant dissolution test
Acceso en liña:	https://www.mdpi.com/1999-4923/17/2/227
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!